NABI BIOPHARMACEUTICALS 6/28/2003

Company

Vaxart, Inc.

Filed

July 25, 2003

Period of Report

June 28, 2003

Accession Number

0000950144-03-008893

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →